Elizabeth McKenna: The July issue of Cancer Discovery is now online
Elizabeth McKenna shared a post on LinkedIn:
“The July issue of Cancer Discovery is now online!
The cover features provocative work by Matheus Henrique Dias, Rene Bernards, and colleagues at The Netherlands Cancer Institute providing evidence for paradoxical activation of oncogenic signaling as a cancer treatment strategy. Read here.
Also in this issue: a review on tumor promoters and opportunities for molecular cancer prevention by Charles Swanton and colleagues, an update on Cancer Core Europe by Javier Carmona Sanz, Josep Tabernero and colleagues, and much more!
Read the issue here.”
Source: Elizabeth McKenna/LinkedIn
Elizabeth McKenna is the Executive Director of Cancer Discovery at the American Association for Cancer Research. Elizabeth earned her PhD from Harvard University and trained with Dr. Charles Roberts at the Dana-Farber Cancer Institute. Her research was among the first to show that pediatric tumors characterized by mutations in chromatin remodelers are genomically stable and instead driven by epigenetic deregulation of key target genes. She joined Cancer Discovery shortly after its launch as its founding Science Writer and became an editor in 2014, rising through the editorial ranks to become the journal’s Executive Editor in 2019. She is a member of the 40 Under 40 in Cancer Class of 2021.
